Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/ZYVERSA-THERAPEUTICS-INC-148115421/nieuws/ZyVersa-Therapeutics-Inc-Kondigt-IRB-goedkeuring-aan-van-het-Fase-2A-klinisch-onderzoeksprotocol-v-46239159/?utm_source=whatsapp&utm_medium=social&utm_campaign=share